🔗 Permalink

Inventor profile of:

Peter Kiener

City:

Potomac, Maryland

Country:

United States

Published Applications:

Last publication date:

2025-03-27

Top Assignees for applications by Peter Kiener

The entities that hold a legal rights for patent applications filed by inventor Kiener Peter:

MEDIMMUNE, LLC 18 Gaithersburg, MD United States
MEDIMMUNE, INC. 5 Gaithersburg, MD United States
The Feinstein Institute For Medical Research 3 Manhasset, NY United States
Zyngenia, Inc. 3 Washington, DC United States
AstraZeneca AB 2 Sodertalje, Sweden
Medlmmune, LLC 2 Gaithersburg, MD United States
Zyngenia, Inc. 2 Gaithersburg, MD United States
CRITICAL THERAPEUTICS 1 LEXINGTON, MA United States
Zygenia, Inc. 1 Washington, DC United States
Medlmmune, Inc 1 Gaithersburg, MD United States
Critical Therapeutics, Inc. 1 Lexington, MA United States
Zyngenia, Inc. 1 Rockville, MD United States
Vironovative B.V. 1 Rotterdam, Netherlands

Recent patent applications by Kiener Peter

Peter Kiener from Potomac, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-03-27

US20250101116A1

Chemistry; metallurgy

ANTI-IFNAR1 ANTIBODIES WITH REDUCED FC LIGAND AFFINITY

#2 | 2024-12-19

US20240417460A1

Chemistry; metallurgy

HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE

#3 | 2021-03-04

US20210061906A1

Chemistry; metallurgy

HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE

#4 | 2020-06-04

US20200172625A1

Chemistry; metallurgy

ANTI-IFNAR1 ANTIBODIES WITH REDUCED FC LIGAND AFFINITY

#5 | 2020-02-20

US20200055944A1

Chemistry; metallurgy

ANTI-IFNAR1 ANTIBODIES WITH REDUCED FC LIGAND AFFINITY

#6 | 2018-09-27

US20180273621A1

Chemistry; metallurgy

HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE

#7 | 2018-08-30

US20180244791A1

Chemistry; metallurgy

Anti-IFNAR1 antibodies with reduced Fc ligand affinity

#8 | 2018-05-03

US20180118839A1

Chemistry; metallurgy

Anti-IFNAR1 antibodies with reduced Fc ligand affinity

#9 | 2018-03-15

US20180072783A1

Chemistry; metallurgy

Polynucleotides encoding angiopoietin-2 (ang-2) binding polypeptides

#10 | 2017-10-19

US20170298106A1

Chemistry; metallurgy

Multivalent and monovalent multispecific complexes and their uses

#11 | 2017-04-13

US20170101468A1

Chemistry; metallurgy

HUMAN ANTI IL-6 ANTIBODIES WITH EXTENDED IN VIVO HALF-LIFE AND THEIR USE IN TREATMENT OF ONCOLOGY, AUTOIMMUNE DISEASES AND INFLAMMATORY DISEASES

#12 | 2016-06-23

US20160176934A1

Chemistry; metallurgy

Ang-2-binding modular recognition domain complexes and pharmaceutical compositions thereof

#13 | 2016-05-26

US20160145335A1

Chemistry; metallurgy

Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease

#14 | 2016-02-18

US20160046678A1

Chemistry; metallurgy

EGFR-binding modular recognition domains

#15 | 2015-07-30

US20150210765A1

Chemistry; metallurgy

Multivalent and Monovalent Multispecific Complexes and Their Uses

#16 | 2015-05-28

US20150147336A1

Chemistry; metallurgy

INTERFERON ALPHA-INDUCED PHARMACODYNAMIC MARKERS AND USES THEREOF

#17 | 2015-05-14

US20150132313A1

Chemistry; metallurgy

INTERFERON ALPHA-INDUCED PHARMACODYNAMIC MARKERS

#18 | 2015-02-12

US20150044222A1

Chemistry; metallurgy

INTERFERON ALPHA-INDUCED PHARMACODYNAMIC MARKERS AND USES THEREOF

#19 | 2014-10-09

US20140302058A1

Chemistry; metallurgy

HUMAN ANTI IL-6 ANTIBODIES WITH EXTENDED IN VIVO HALF-LIFE AND THEIR USE IN TREATMENT OF ONCOLOGY, AUTOIMMUNE DISEASES AND INFLAMMATORY DISEASES

#20 | 2014-03-06

US20140065142A1

Chemistry; metallurgy

Multivalent and Monovalent Multispecific Complexes and Their Uses

#21 | 2013-10-03

US20130259868A1

Chemistry; metallurgy

Ang-2 Binding Complexes and Uses Thereof

#22 | 2013-05-09

US20130115657A1

Chemistry; metallurgy

Humanized anti-CD19 antibodies

#23 | 2012-06-07

US20120141463A1

Physics

Method of identifying membrane Ig specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells

#24 | 2012-04-26

US20120100166A1

Chemistry; metallurgy

Ang-2 Binding Complexes and Uses Thereof

#25 | 2011-11-24

US20110287023A1

Chemistry; metallurgy

High affinity antibodies against HMGB1 and methods of use thereof

#26 | 2011-11-24

US20110287022A1

Chemistry; metallurgy

INTERFERON ALPHA-INDUCED PHARMACODYNAMIC MARKERS

#27 | 2011-09-29

US20110236406A1

Chemistry; metallurgy

IMMUNOGENIC COMPOSITIONS COMPRISING HMGB1 POLYPEPTIDES

#28 | 2011-03-10

US20110059078A1

Chemistry; metallurgy

ANTI-IFNAR1 ANTIBODIES WITH REDUCED FC LIGAND AFFINITY

#29 | 2011-01-13

US20110008329A1

Chemistry; metallurgy

Methods of Treating RSV Infections And Related Conditions

#30 | 2010-11-04

US20100278838A1

Chemistry; metallurgy

EPHA2 MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF

#31 | 2010-11-04

US20100278813A1

Chemistry; metallurgy

Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies

#32 | 2010-10-14

US20100261172A1

Chemistry; metallurgy

INTERFERON ALPHA-INDUCED PHARMACODYNAMIC MARKERS

#33 | 2010-06-10

US20100143372A1

Human necessities

INTERFERON ALPHA-INDUCED PHARMACODYNAMIC MARKERS

#34 | 2010-04-15

US20100093611A1

Human necessities

COMPOUNDS AND METHODS FOR TREATING OR PREVENTING AUTOIMMUNE DISEASES

#35 | 2010-03-11

US20100061987A1

Chemistry; metallurgy

High affinity antibodies against HMGB1 and methods of use thereof

#36 | 2009-07-02

US20090169546A1

Chemistry; metallurgy

High affinity antibodies against HMGB1 and methods of use thereof

#37 | 2009-05-21

US20090130111A1

Physics

Method of identifying membrane IgE specific antibodies and use thereof for targeting IgE producing precursor cells

#38 | 2008-12-18

US20080311122A1

Chemistry; metallurgy

Antagonists of Hmgb1 and/or Rage and Methods of Use Thereof

#39 | 2008-12-11

US20080305120A1

Chemistry; metallurgy

Immunogenic Compositions Comprising Hmgb 1 Polypeptides

#40 | 2008-07-31

US20080181887A1

Chemistry; metallurgy

Molecules with extended half-lives, compositions and uses thereof

#41 | 2008-06-12

US20080138336A1

Chemistry; metallurgy

Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease

#42 | 2007-07-19

US20070166314A1

Chemistry; metallurgy

EpA2 monoclonal antibodies and methods of use thereof

#43 | 2006-05-11

US20060099207A1

Chemistry; metallurgy

High affinity antibodies against HMGB1 and methods of use thereof

#44 | 2005-08-11

US20050175616A1

Chemistry; metallurgy

PCDGF receptor antibodies and methods of use thereof

InventorID:

235107 ⎘